Papers: 9 Apr 2012 - 16 Apr 2012
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome.
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE.
MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Endovascular correction of cerebrovenous anomalies in Multiple Sclerosis: A retrospective review of an uncontrolled case series.
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis.
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Conference Report: Multiple Sclerosis Update: Hot topics from 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences.
Implications of water channel proteins in selected neurological disorders: Epilepsies, muscular dystrophies, amyotrophic lateral sclerosis, neuromyelitis optica, Parkinson's disease, and spongiform encephalopathies.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.